Predictors of Sepsis in Ex-Preterm Infants
The aims of this study are to:
- Assess whether ex-preterm infants have a persistently immature immune system, which may decrease their ability to respond to infections, when they reach term-corrected gestational age.
- Examine whether clinical history, nutrition status, and microbiome composition are linked to the immune composition of term and ex-preterm infants and whether these variables can be used to predict the risk of developing sepsis or having an immunologic disease.
Studieöversikt
Status
Betingelser
Detaljerad beskrivning
Preterm infants have increased numbers of viral infections in childhood. They are also more likely to die from infection during the neonatal and infant periods than infants born at term. While studies have demonstrated that premature infants have decreased adaptive and innate immune responses compared with infants born at term, there has been little investigation into whether this impaired immunity improves and becomes similar to full term infants once the ex-preterm infants reach term-corrected gestational age. There have likewise not been studies to determine whether specific immune markers may predict the risk of developing sepsis. Given the immaturity of the preterm immune system and the many potential infectious and inflammatory insults they are exposed to during the preterm period (infections, poor nutrition, stress, steroid therapy), there is also a possibility that the relative immune deficiency experienced by preterm infants may persist into infancy.
The goal of this study is to determine whether former preterm infants have sustained differences in immunity compared to age-matched controls, which would have significant implications for infection risk and response to vaccination. Additionally, this study hopes to examine whether certain immune system abnormalities make certain babies more likely to have a serious infection. The present study will assess composition and function of T and B cell compartments in preterm and former preterm infants.
Studietyp
Inskrivning (Faktisk)
Kontakter och platser
Studieorter
-
-
Massachusetts
-
Boston, Massachusetts, Förenta staterna, 02115
- Boston Children's Hospital
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Testmetod
Studera befolkning
Beskrivning
Inclusion Criteria Ex-Preterm Infant Group:
- Infants born less than 37 weeks gestational age
Exclusion Criteria for Ex-Preterm Infant Group:
- Infants born greater than 37 weeks gestational age
Inclusion Criteria for Term Infant Group:
- Infants born greater than 37 weeks gestational age
Exclusion Criteria for Term Infant Group:
- Infants born less than 37 weeks gestational age
Studieplan
Hur är studien utformad?
Designdetaljer
Kohorter och interventioner
Grupp / Kohort |
|---|
|
Preterm Infants
Blood samples will be obtained from preterm and former preterm infants at birth and then monthly until hospital discharge.
The sample would consist of either up to 0.5ml of blood obtained during a requested clinical blood draw, discarded blood, or a dried blood spot specimen.
If no discard samples are available and study blood samples need to be obtained instead, this will occur for a maximum period of 6 months and no more than 3ml of blood will be collected over the entire study period.
|
|
Term Infants
Blood samples will be obtained from term control infants admitted to the NICU monthly until hospital discharge.
The sample would consist of either up to 0.5ml of blood obtained during a requested clinical blood draw, discarded blood, or a dried blood spot specimen.
If no discard samples are available and study blood samples need to be obtained instead, this will occur for a maximum period of 6 months and no more than 3ml of blood will be collected over the entire study period.
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
The presence or absence of skewed or altered immune profile in preterm infants compared to infants born at term.
Tidsram: Up to 1 year
|
The present study will assess composition and function of T and B cell compartments in preterm and former preterm infants.
Whole blood samples will be separated into serum and cellular components and sera will be used to assess cytokine predominance and measure nutritional markers.
|
Up to 1 year
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Determining whether non-modifiable variables of nutrition status, microbiome composition, or immune repertoire composition predict risk of developing infection during the hospitalization.
Tidsram: Up to 1 year
|
The investigators will measure nutritional status.
Whole blood samples will be separated into serum and cellular components and sera will be used to assess cytokine predominance and measure nutritional markers.
|
Up to 1 year
|
Samarbetspartners och utredare
Sponsor
Utredare
- Huvudutredare: Amy O'Connell, MD, Boston Children's Hospital
Studieavstämningsdatum
Studera stora datum
Studiestart (Faktisk)
Primärt slutförande (Faktisk)
Avslutad studie (Faktisk)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Faktisk)
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Nyckelord
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- IRB-P00023454
Plan för individuella deltagardata (IPD)
Planerar du att dela individuella deltagardata (IPD)?
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Studerar en amerikansk FDA-reglerad produktprodukt
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .
Kliniska prövningar på Sepsis
-
University of California, San FranciscoNational Cancer Institute (NCI)RekryteringSepsis | Sepsis, svår | Sepsis och septisk chock | Sepsis på intensivvårdsavdelningen | Sepsis, septisk chock | Sepsis, Svår Sepsis och Septisk Shock | Sepsis med multipel organdysfunktion (MOD) | Sepsis med akut organdysfunktionFörenta staterna
-
University of Kansas Medical CenterUniversity of KansasRekryteringSepsis | Septisk chock | Sepsis syndrom | Sepsis, svår | Sepsis bakterie | Sepsis bakteriemiFörenta staterna
-
Jip GroenInBiomeRekryteringMikrobiell kolonisering | Neonatal infektion | Neonatal sepsis, tidig debut | Mikrobiell sjukdom | Klinisk sepsis | Kultur Negativ Neonatal Sepsis | Neonatal sepsis, sen debut | Kultur Positiv neonatal sepsisNederländerna
-
Karolinska InstitutetÖrebro University, SwedenAvslutadSepsis | Sepsis syndrom | Sepsis, svårSverige
-
Ohio State UniversityAvslutadSepsis, Svår Sepsis och Septisk ShockFörenta staterna
-
University of LeicesterUniversity Hospitals, Leicester; The Royal College of AnaesthetistsAvslutadSepsis | Septisk chock | Svår sepsis | Sepsis syndromStorbritannien
-
Chinese University of Hong KongRekryteringSepsis | Septisk chock | Sepsis och septisk chock | Sepsis på intensivvårdsavdelningen | Sepsis - för att minska dödligheten på intensivvårdsavdelningenHong Kong
-
Indonesia UniversityAvslutadSvår sepsis med septisk chock | Svår sepsis utan septisk chockIndonesien
-
Beckman Coulter, Inc.Biomedical Advanced Research and Development AuthorityAnmälan via inbjudanSvår sepsis | Svår sepsis utan septisk chockFörenta staterna
-
McMaster UniversitySepsis Canada NetworkHar inte rekryterat ännuSepsis | Sepsis och septisk chock | Sepsis på intensivvårdsavdelningen